Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03311334
Title A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Subjects With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc

head and neck squamous cell carcinoma

renal cell carcinoma


lung non-small cell carcinoma

transitional cell carcinoma


Atezolizumab + DSP-7888

DSP-7888 + Nivolumab

Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.